We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 11,537

FDA Approves Software Application That Alerts Providers of Potential Stroke in Patients
  • Drinker Biddle & Reath LLP
  • USA
  • February 23 2018

On February 13, 2018 FDA approved a software application with clinical-decision support capability, in this case alerting providers of a potential


Taking Pills for Pay: FDA Releases Information Sheet on Paying Research Subjects
  • Baker Donelson Bearman Caldwell & Berkowitz PC
  • USA
  • February 22 2018

In clinical research, compensating research subjects as an incentive for their participation is a common practice. However, paying research subjects


Seizure-Detecting Smart Watch Given FDA Approval
  • Knobbe Martens
  • USA
  • February 22 2018

The FDA has recently approved Embrace, a smart watch designed to monitor epileptic patients for seizures, according to a press release. According to


CRISPR: The New Frontier of Biotechnology Innovation
  • Paul Hastings LLP
  • USA
  • February 22 2018

By now, life sciences IP attorneys have probably heard about clustered regularly interspaced short palindromic repeats. In short, they are the


Top 7 Legal Challenges Facing Physicians and Hospitals
  • Jackson Lewis PC
  • USA
  • February 21 2018

The American Health Lawyers Association’s 2018 Physicians and Hospitals Law Institute in New Orleans focused on the legal challenges faced by


Amicus Briefs Filed in Support of Deeming Rule Appeal by Washington Legal Foundation, NJOY, CASAA, the State of Iowa and Clive Bates, et al.
  • Keller and Heckman LLP
  • USA
  • February 21 2018

On February 20, 2018 several organizations filed amicus (“friend of the court”) briefs in support of Plaintiff-Appellants Nicopure Labs’ and the Right


Food and Beverage News and Trends
  • DLA Piper
  • USA
  • February 21 2018

This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape


Lupin’s Generic Version of Tamiflu Joins the Band of Flu Fighters
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • February 20 2018

Mumbai-based pharmaceutical manufacturer Lupin recently received FDA approval for its generic version of Roche’s Tamiflu (oseltamivir phosphate), one


New DOJ Guidance Policy Limits Use of Guidance Documents in Federal Civil Actions
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • February 20 2018

On January 25, 2018, Associate Attorney General Rachel Brand issued a memorandum on behalf of the U.S. Department of Justice (DOJ) (the “Brand


FDA Guidance on Regulatory Classification of Pharmaceutical Co-Crystals
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • February 20 2018

On February 14, 2018, FDA released a final guidance titled “Regulatory Classification of Pharmaceutical Co-Crystals Guidance for Industry.” The